We previously found that docosahexaenoic acid (DHA) intake prevented aggression from increasing at times of mental stress. In the present study, we investigated whether DHA intake modified the plasma catecholamines and cortisol of medical students during a 9-wk period of final exams. We also investigated the effects of DHA intake on a 75g oral glucose tolerance test (oGTT). Fourteen medical students participated in the present study. They were randomly allocated to either control or DHA group in a double-blind manner. Subjects in the control group (4 males and 3 females) took 10 control capsules/d, each capsule containing 280mg of mixed plant oil, and those in the DHA group (4 males and 3 females) took 10 DHA capsules/d containing 1.5g DHA for 9 wk, during which subjects underwent more than 20 stressful final exams. At the start and end of the study, plasma catecholamines (epinephrine, norepinephrine (NE) and dopamine) and cortisol were measured; a 75g oGTT was also performed. There were no intra-or intergroup differences in plasma glucose concentrations. However, NE concentrations were significantly reduced after DHA administration (-31%, p<0.03). The other catecholamines and cortisol did not change significantly. The plasma ratio of epinephrine to NE increased in every DHA subject (+78%, p<0.02), and intergroup differences were sig nificant (p<0.03). We conclude that these effects of DHA may be ap plied to people under long-lasting psychological stress to prevent stress-related diseases.
Summary
We previously found that docosahexaenoic acid (DHA) intake prevented aggression from increasing at times of mental stress. In the present study, we investigated whether DHA intake modified the plasma catecholamines and cortisol of medical students during a 9-wk period of final exams. We also investigated the effects of DHA intake on a 75g oral glucose tolerance test (oGTT). Fourteen medical students participated in the present study. They were randomly allocated to either control or DHA group in a double-blind manner. Subjects in the control group (4 males and 3 females) took 10 control capsules/d, each capsule containing 280mg of mixed plant oil, and those in the DHA group (4 males and 3 females) took 10 DHA capsules/d containing 1.5g DHA for 9 wk, during which subjects underwent more than 20 stressful final exams. At the start and end of the study, plasma catecholamines (epinephrine, norepinephrine (NE) and dopamine) and cortisol were measured; a 75g oGTT was also performed. There were no intra-or intergroup differences in plasma glucose concentrations. However, NE concentrations were significantly reduced after DHA administration (-31%, p<0.03). The other catecholamines and cortisol did not change significantly. The plasma ratio of epinephrine to NE increased in every DHA subject (+78%, p<0.02), and intergroup differences were sig nificant (p<0.03). We conclude that these effects of DHA may be ap plied to people under long-lasting psychological stress to prevent stress-related diseases.
Recently, several lines of evidence have indicated that the behavior of both animals and humans is affected by dietary fatty acids. Mice fed an n-3 fatty acid-deficient diet and an n-3-sufficient diet for two generations had different general behaviors as well as sensitivities to behavior-affecting drugs (1). Rats on an n-3-deficient diet showed more aggressive behavior at a brightness-discrimination test than those on an n-3-sufficient diet (2). Behavioral changes have been observed also in rhesus monkeys. N-3-deficient monkeys initiate more bouts of stereo-typed behavior in their home cages than those fed an n-3-sufficient (soybean oil as the only source of fat) control diet (3). Moreover, there is an association between the blood n-3 fatty acid status and behavior problems in children. Investigating 6-12-y-old boys, Stevens et al (4) showed that a greater number of behavior pro blems, temper tantrums and sleep problems were reported in subjects with lower total n-3 fatty acid concentrations in the plasma phospholipid fraction.
In this context, we performed a randomized placebo-controlled double-blind study using young Japanese students (5) whose n-3 fatty acid intake was much lower than average Japanese people (6). We administered 1.5-1.8g docosahexaenoic acid (DHA)/d to students of the DHA group for 3 mo. We measured the aggressiveness of the students at the start and end of the study. Because of the presence of stressor at the end of the study (final exams that were of vital importance to students), the averaged aggressiveness was significantly increased in the control group, but it stayed the same as before in the DHA group. From these findings, we concluded that DHA intake prevented aggressiveness from increasing at times of mental stress (5).
Today, a considerable body of evidence links increased aggressive behaviors with decreased central nervous system (CNS) serotonin function (7, 8). Low cerebrospinal 5-hydroxyindoleacetic acid concentration, an indicator of reduced serotonin turnover rate in the frontal cortex (9), has actually been associated with hostility (10) and aggressive behavior (11). Interestingly, there is an association between plasma long-chain polyunsaturated fatty acids including DHA and 5-hydroxyindoleacetic acid in cerebrospinal fluid in healthy volunteers (12). Also, reduced CNS serotonin function increases catecholamine (CA) outflow (7). Therefore, if the aggression-controlling effects by DHA intake (5) are mediated by increased CNS serotonin function, we could expect that DHA administration might modify peripheral CA levels.
Here, we report another intervention study using medical students to test the effect of DHA administration on CA levels during a 9-wk final exam period. In the present study we also performed a 75 g oral glucose tolerance test (oGTT) considering that glucose tolerance might be enhanced during DHA treatment if CA levels are lowered. 
RESULTS
Exclusion of improper subjects One male control subject dropped out of the study before the second blood sampling at the end of the study for personal reasons. One female control subject was excluded from the study because she suffered from mild primary shock during the first blood sampling. Two DHA subjects (one male and one female) finished the whole course of the study, but the second blood sampling at the end of the study was performed 2 d after they took their last exams. We, therefore, excluded those subjects before the double-blind code was open. The questionnaire performed at the end of the study showed that no subjects of either group complained of any serious adverse effects from taking capsules, and that subjects did not infer the kind of their own capsules more correctly than by chance.
Combination of data of both sexes We could not find any marked differences between the two sexes in any measured items within any group. Consequently, we combined the data of both sexes.
RBC fatty acid composition and lipid intake
Changes in the major fatty acids in the RBC total phospholipid fraction are shown in Table 1 . In the control group, there were no significant changes in any fatty acids, whereas EPA and DHA increased significantly in the DHA group. The DHA concentration increased in every DHA subject. If capsules were not taken into account, averaged DHA intake from food was 27 and 19mg/d for the control and DHA groups, respectively (not significantly different). There were no significant differences in the average intake of total lipids and total energy between the two groups.
Plasma glucose and serum insulin levels As shown in Table 2 , there were no significant intra-or intergroup differences in the plasma glucose or serum insulin levels. Fig. 1. Changes in plasma EP/NE ratios before and after capsule administration. Subjects took 10 capsules of either placebo or DHA-rich fish oil for 9 wk. Data were log-transformed for normalization. The averaged increase in the DHA group was +78% (10%-188%, mean-SD-mean+SD). * p<0.02 by paired t-test, p<0.03 by ANOVA.
CA and cortisol levels
As shown in Table 3 , there were no significant differences in dopamine, EP and cortisol levels between the two groups. NE levels decreased significantly in the DHA group (-31%, p<0.03 by paired t-test, p<0.10 by ANOVA), whereas the levels were stable in the control group. The ratio of EP to NE was increased in every DHA subject (+78%,p<0.02 by paired t-test); the increases were significantly different from the controls (p<0.03 by ANOVA, Fig. 1 ).
DISCUSSION
The duration of the present study was 9 wk. We could not find a longer period of stress, essentially identical to all subjects, in any homogeneous population accustomed to blood sampling and that might volunteer to enter the present study. That was why we chose this 9-wk period of continuous stress. Since the subjects had known the coming 9-wk period of considerable stress long before the start of the present study, they had already been under considerable psychological stress when we started administering capsules. Indeed, their baseline values of plasma NE were already rather high (Table 3) , which means DHA supplementation was able to modulate CA metabolism even after the appearance of stress . This point is noteworthy when applying the results of the present study to daily life where a countermeasure to stress is usually taken only after it starts.
The most important finding in the present study is that plasma EP/NE ratios were significantly increased in the DHA group as compared to the control group . Recently, Christensen and Schultz-Larsen (15) measured basal plasma CA levels of 804 (412 males) people of 70y of age and followed them for 7y. During that period 115 males died. An analysis of plasma CA levels revealed that 10% of the male subjects with high plasma EP and low NE levels had died 7y later, whereas 50% of the male subjects with low plasma EP and high NE had died (15) . Plasma EP levels increase during acute mental stress, but no close correlation has been established between plasma EP levels and chronic stress (16). Indeed,, psychological stress in patients with duodenal ulcer did not increase plasma EP levels but in creased NE levels (17) . Basal plasma EP and cortisol levels may represent the adrenal capacity to cope with stress; therefore, an inadequate response of EP to chronic psychological stress may be harmful (16). The plasma CA balance in the DHA group became similar to that of the longevity group of 70-y-old males (15) and did not suggest relative EP insufficiency even after long-lasting psy chological stress.
As can be seen from Table 3 , the change in plasma NE levels in the DHA group was the major contributor to the increase in EP/NE ratios. Christensen and Schultz-Larsen (15) reported that the mean basal NE values of males who died of cardiovascular diseases (2.43nmol/L) were significantly higher than those of male survivors (1.95nmol/L). Consequently, a decrease in plasma NE as shown in the DHA group is likely beneficial to the cardiovascular system . There are several fish oil intervention trials measuring plasma NE. Singer et al (18) randomly allocated 47 hypertensives to the following three groups and treated them for more than 36 wk: Group P was treated with propranolol alone; Group F with fish oil alone; and Group P+F, which was first treated with propranolol, then with propranolol plus fish oil, and finally with propranolol plus fish oil placebo. They found that, after fish oil supplementation, plasma NE levels were reduced to 80% of the baseline value in Group F and 56% of that in Group P+F. The reduction levels of plasma NE were similar to our study (18) . However, their findings were excep tional because no other controlled studies have found any significant decreases in plasma NE during fish oil treatment with normal subjects (19, 20) or mild hy pertensives (19, (21) (22) (23) . Although experimental protocols differed from study to study and no direct comparison of these studies seemed possible, the plasma NE levels before fish oil administration were rather high in the study of Singer et al (18) that found the NE-reducing activity of fish oil. Our subjects had also rather high baseline plasma NE levels. Consequently, high pre-values of NE might be one of the factors that determined whether fish oil reduces NE or not. In the present study, we carefully took blood samples for CA, and subjects were medical students 
